Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

VolitionRx shows biomarker-driven lung cancer insights at NACLC 2025

Written by | 10 Dec 2025

VolitionRx Limited, announces the presentation of two abstracts at the North America Conference on Lung Cancer (NACLC) in Chicago recently. The posters highlighted the use of its Nu.Q® Cancer… read more.

How to double lung cancer screening rates

Written by | 21 Oct 2025

Lung cancer screening might be the best-kept secret in health care today. Only about 16 percent of those who are eligible in the U.S. get screened for lung… read more.

Actinium Pharmaceuticals to share new radiotherapy research on ATNM-400 across solid tumors at AACR-NCI-EORTC 2025

Written by | 18 Oct 2025

Actinium Pharmaceuticals, Inc.), a leader in the development of differentiated targeted radiotherapies  announced that the first-ever preclinical data from its ATNM-400 program in non-small cell lung cancer (NSCLC)… read more.

Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds

Written by | 16 Sep 2025

Older individuals between the ages of 75 and 80 who are eligible for lung surgery may achieve survival outcomes comparable to younger patients following lung cancer screening, according… read more.

Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy

Written by | 14 Sep 2025

Patients who underwent video-assisted thoracoscopic surgery (VATS) compared to open lobectomy had a significantly improved overall survival rate, according to a meta-analysis presented at the International Association for the… read more.

Daiichi Sankyo to present new lung cancer research at WCLC 2025

Written by | 15 Aug 2025

Daiichi Sankyo will present new clinical research across its DXd antibody drug conjugate (ADC) portfolio in lung cancer at the IASLC 2025 World Conference on Lung Cancer hosted… read more.

Imfinzi-based perioperative regimen approved in the EU for resectable non-small cell lung cancer – AstraZeneca

Written by | 1 Aug 2025

AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been approved in the European Union (EU) for the treatment of adults with resectable non-small cell lung cancer (NSCLC) at… read more.

Increased use of chest x-rays linked to earlier lung cancer diagnosis and improved survival

Written by | 31 Mar 2025

A groundbreaking study has revealed a significant link between the frequency of chest x-ray referrals from GPs and earlier diagnosis and improved survival rates for lung cancer patients.    … read more.

New data from three oral presentations, showing significant clinical benefit with Sarclisa-based quadruplets in newly diagnosed multiple myeloma patients presented at ASH meeting – Sanofi

Written by | 11 Jan 2025

New data from three oral presentations, which demonstrated significant clinical benefit with Sarclisa-based quadruplets in newly diagnosed multiple myeloma (NDMM) patients were featured at the 66th American Society… read more.

CT scans for lung cancer show potential for detecting elevated coronary artery calcium

Written by | 7 Dec 2024

Lung cancer screening with low-dose chest computed tomography (CT) has the potential to detect coronary artery calcium too, researchers reported on Dec. 2, 2024 in the CMAJ (Canadian Medical Association… read more.

Lung cancer screening CTs find coronary artery disease in 83% of cases

Written by | 3 Dec 2024

Lung cancer screening with low-dose chest computed tomography (CT) may detect more than just lung cancer. As new research in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.231602 shows, these CTs can identify coronary… read more.

Awareness of lung cancer screening remains low

Written by | 10 Nov 2024

There is a lung cancer screening test that is saving lives – and yet most people who could be getting the test have never heard of it or… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.